INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
DA
Dudum AndrewDirector, Chief Executive Officer, 10% Owner
HIMSHims & Hers Health, Inc.
Gift
G—
422.9K sh
Apr 9, 2026Apr 10, 2026
Page 981 of 1737
← PrevNext →
traded Apr 9, 2026
+1d
SEC Form 4

Evidence

24
BT
Bailey TabithaSVP & Chief Legal Officer
SNDASONIDA SENIOR LIVING, INC.
Grant or award
A—
55.0K sh
Feb 23, 2026Apr 10, 2026
traded Feb 23, 2026
+46dSEC Form 4

Evidence

24
MA
Makkai AndreaPrincipal Accounting Officer
ULYXUrgent.ly Inc.
Grant or award
A$54K
10.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

24
RB
Ribar BrandonDirector, President & CEO
SNDASONIDA SENIOR LIVING, INC.
Grant or award
A—
275.0K sh
Feb 23, 2026Apr 10, 2026
traded Feb 23, 2026
+46dSEC Form 4

Evidence

24
DA
Dudum AndrewDirector, Chief Executive Officer, 10% Owner
HIMSHims & Hers Health, Inc.
Gift
G—
422.9K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

24
LM
Levy MaxSVP & Chief Investment Officer
SNDASONIDA SENIOR LIVING, INC.
Grant or award
A—
130.0K sh
Feb 23, 2026Apr 10, 2026
traded Feb 23, 2026
+46dSEC Form 4

Evidence

24
BT
Bailey TabithaSVP & Chief Legal Officer
SNDASONIDA SENIOR LIVING, INC.
Tax withholding
F$12K
402 sh
Dec 9, 2025Apr 10, 2026
traded Dec 9, 2025
+122dSEC Form 4

Evidence

24
CT
Cober TimothySVP & Chief Accounting Officer
SNDASONIDA SENIOR LIVING, INC.
Grant or award
A—
55.0K sh
Feb 23, 2026Apr 10, 2026
traded Feb 23, 2026
+46dSEC Form 4

Evidence

24
KP
Kennedy Susan PDirector, Chief Executive Officer
CDZICADIZ INC
Option exercise
M—
50.0K sh
Oct 31, 2025Apr 10, 2026
traded Oct 31, 2025
+161dSEC Form 4

Evidence

24
MP
Murphy Martin PatrickDirector
IPSCCentury Therapeutics, Inc.
Grant or award
A—
88.0K sh
Dec 9, 2025Apr 10, 2026
traded Dec 9, 2025
+122dSEC Form 4

Evidence

23
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9,340
100 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

23
CT
Cober TimothySVP & Chief Accounting Officer
SNDASONIDA SENIOR LIVING, INC.
Disposition to issuer
D—
1,957 sh
Mar 9, 2026Apr 10, 2026
traded Mar 9, 2026
+32dSEC Form 4

Evidence

23
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9,340
100 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

23
RB
Ribar BrandonDirector, President & CEO
SNDASONIDA SENIOR LIVING, INC.
Disposition to issuer
D—
14.4K sh
Mar 9, 2026Apr 10, 2026
traded Mar 9, 2026
+32dSEC Form 4

Evidence

23
DK
Detz KevinEVP & Chief Financial Officer
SNDASONIDA SENIOR LIVING, INC.
Disposition to issuer
D—
9,134 sh
Mar 9, 2026Apr 10, 2026
traded Mar 9, 2026
+32dSEC Form 4

Evidence

23
KC
Kidwell CaseyChief Administration Officer
AAONAAON, INC.
Grant or award
A—
981 sh
Mar 11, 2026Apr 10, 2026
traded Mar 11, 2026
+30dSEC Form 4

Evidence

23
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1,288
14 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

22
BC
Billingsley ChesterDirector, Chief Executive Officer, 10% Owner
MNTRMentor Capital, Inc.
Open-market purchase
BUY$57
950 sh
Apr 10, 2026Apr 10, 2026
traded Apr 10, 2026
+0dSEC Form 4

Evidence

22
RB
Ribar BrandonDirector, President & CEO
SNDASONIDA SENIOR LIVING, INC.
Tax withholding
F$237K
6,472 sh
Mar 9, 2026Apr 10, 2026
traded Mar 9, 2026
+32dSEC Form 4

Evidence

22
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
1,683 sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC Form 4

Evidence

22
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$49K
14.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$55K
7,734 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
BC
Billingsley ChesterDirector, Chief Executive Officer, 10% Owner
MNTRMentor Capital, Inc.
Open-market purchase
BUY$65.1
1,050 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

22
DK
Detz KevinEVP & Chief Financial Officer
SNDASONIDA SENIOR LIVING, INC.
Tax withholding
F$107K
2,917 sh
Mar 9, 2026Apr 10, 2026
traded Mar 9, 2026
+32dSEC Form 4

Evidence

22
BC
Billingsley ChesterDirector, Chief Executive Officer, 10% Owner
MNTRMentor Capital, Inc.
Open-market purchase
BUY$124
2,000 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

21
PJ
Pawlowski JohnPresident and CEO
AVOMission Produce, Inc.
Grant or award
A—
42.1K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

21
LM
Liebowitz MichaelDirector, President and CEO
DOUGDouglas Elliman Inc.
Grant or award
A—
1.25M sh
Apr 10, 2026Apr 10, 2026
traded Apr 10, 2026
+0dSEC Form 4

Evidence

21
BH
Brodie Bradley HarrisSVP, General Counsel,Secretary
DOUGDouglas Elliman Inc.
Grant or award
A—
175.0K sh
Apr 10, 2026Apr 10, 2026
traded Apr 10, 2026
+0dSEC Form 4

Evidence

21
GC
Gibson ChristopherDirector
PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Grant or award
A—
57.5K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

21
KP
Kennedy Susan PDirector, Chief Executive Officer
CDZICADIZ INC
Disposition to issuer
D—
150.5K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

21
FJ
Flanagan Laura JeanDirector
AVOMission Produce, Inc.
Grant or award
A—
8,240 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

20
BM
Booth MatthewDirector, Chief Executive Officer
ULYXUrgent.ly Inc.
Grant or award
A$124K
23.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

20
SL
Spikes Brent LVP, Global Manufacturing Ops
FELEFRANKLIN ELECTRIC CO INC
Grant or award
A$130K
1,307 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

20
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.35M
10.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

19
SP
Srinivasan PriyaChief People & Purpose Officer
COTYCOTY INC.
Option exercise
M—
4,741 sh
Apr 4, 2026Apr 10, 2026
traded Apr 4, 2026
+6dSEC Form 4

Evidence

19
CT
Cober TimothySVP & Chief Accounting Officer
SNDASONIDA SENIOR LIVING, INC.
Tax withholding
F$20K
547 sh
Mar 9, 2026Apr 10, 2026
traded Mar 9, 2026
+32dSEC Form 4

Evidence

19
RS
Robins Harlan SChief Scientific Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$149K
10.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

19
SP
Srinivasan PriyaChief People & Purpose Officer
COTYCOTY INC.
Tax withholding
F—
2,347 sh
Apr 4, 2026Apr 10, 2026
traded Apr 4, 2026
+6dSEC Form 4

Evidence

19
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC Form 4

Evidence

19
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC Form 4

Evidence